Background.
We aimed to determine the frequency of alanine aminotransferase (ALT) elevation during interferon-α treatment, the so-called “flare”, its relation to serum beta-2 microglobulin levels, and its impact on the outcome of treatment in chronic hepatitis B. Methods. The files of 53 treatment-naive patients with chronic hepatitis B (17 hepatitis B e antigen (HBeAg) +ve, 36 HBeAg −ve) who had been treated with 10 MU interferon-α 2b three times per week for 24 weeks were reviewed. We analyzed the fluctuations in serum ALT, β2-microglobulin, and HBV-DNA levels before, during, and after flare. Results. We detected flare in 4/17 (24%) of the HBeAg +ve and 7/34 (21%) of the HBeAg −ve patients. ALT level peaked between weeks 2 and 16 (mean, week 8). After flare, HBV-DNA disappeared in 5/7 (71%) HBeAg −ve vs 3/4 (75%) HBeAg +ve patients (all seroconverted to anti-HBe). The overall sustained response rate was 41%: 55% in the patients with flare, and 38% in those without (P > 0.05). Basal serum β2-microglobulin levels were significantly higher in responders vs nonresponders (2.19 ± 0.32 vs 1.78 ± 0.34 mg/l, mean ± SD; P < 0.005). In addition, during treatment, serum β2-microglobulin levels increased significantly only in responders, and the degree of increase was significantly higher in responders with flare vs responders without flare (3 ± 0.33 vs 2.34 ± 0.35 mg/l; P < 0.001). Conclusions. This study, with a limited sample size, showed that, in chronic hepatitis B, there is a trend for a higher response in patients with exacerbation of hepatitis B with interferon-α treatment. However, the difference does not reach statistical significance to be of predictive value. On the other hand, serum β2-microglobulin levels before and during treatment may be useful in predicting the outcome.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Author information
Authors and Affiliations
Additional information
Received: June 4, 2002 / Accepted: October 25, 2002
RID="*"
ID="*" Reprint requests to: H. Senturk
Rights and permissions
About this article
Cite this article
Akdogan, M., Senturk, H., Mert, A. et al. Acute exacerbation during interferon alfa treatment of chronic hepatitis B: frequency and relation to serum β-2 microglobulin levels. J Gastroenterol 38, 465–470 (2003). https://doi.org/10.1007/s00535-002-1083-6
Issue Date:
DOI: https://doi.org/10.1007/s00535-002-1083-6